Replacing organ transplant with an infusion
Our vision is to provide regenerative medicine treatments that free patients from chronic liver disease and help usher in an era where diseased and damaged tissues can be repaired.
What they do:
Unlocking the power of biotech with modern software for modern science
Quick facts:
HQ: San Francisco, CA, United States
What they do:
We make robots for biologists.
Quick facts:
HQ: New York, NY, United States
What they do:
Artificial intelligence for drug discovery.
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$19.8M · Equity · Mar 2026
What they do:
Altay develops disease-modifying therapies targeting transcription…
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$15.7M · Equity · Oct 2026
What they do:
AI drug discovery platform for neurotherapeutics
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$2.16M · Options · Feb 2026
What they do:
Next-generation DNA synthesis using enzymes
Quick facts:
HQ: San Francisco, CA, United States
Replacing organ transplant with an infusion
Bend, OR, United States
4 employees, according to the company profile.
There are no funding rounds for Hepatx in our data.
Similar startups: Benchling, Opentrons, and Numerion Labs.